ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0725
0,00%
Bitcoin
62.993,07
0,17%
Brent Oil
82,765
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Alkermes PLC (ALKS)

  7. Alkermes PLC (ALKS) Notícias

ALKS Alkermes PLC

24,05
0,19 (0,80%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Alkermes PLC ALKS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,19 0,80% 24,05 20:36:06
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
24,14 23,92 24,48 24,05 23,86
mais cotações »

Notícias Recentes

Data Hora Fonte Título
02/05/202408:00PRNUSAlkermes plc Completes Sale of Athlone, Ireland Facility to..
01/05/202408:00PRNUSAlkermes plc Reports First Quarter 2024 Financial Results
24/04/202408:00PRNUSAlkermes Announces Initiation of Vibrance-1 Phase 2 Study..
17/04/202417:00PRNUSAlkermes to Report First Quarter Financial Results on May 1,..
09/04/202408:00PRNUSAlkermes Announces Positive Topline Results From Phase 1b..
08/04/202408:00PRNUSAlkermes Presents Analyses From Long-Term Safety Study of..
07/03/202409:00PRNUSAlkermes Announces Appointment of Nancy S. Lurker to Board..
15/02/202409:00PRNUSAlkermes plc Reports Financial Results for the Fourth..
08/02/202418:00PRNUSAlkermes to Report Fourth Quarter and Year-End Financial..
03/01/202418:00PRNUSAlkermes to Present at the 42nd Annual J.P. Morgan..
03/01/202409:00PRNUSAlkermes Announces Topline Results From Long-Term,..
14/12/202308:05PRNUSAlkermes plc Announces Agreement to Sell Athlone, Ireland..
01/12/202320:16PRNUSUber Technologies, Jabil and Builders FirstSource Set to..
21/11/202318:00PRNUSAlkermes to Participate in Two Upcoming Investor Conferences
15/11/202309:00PRNUSAlkermes Completes Separation of Oncology Business
07/11/202318:00PRNUSAlkermes to Participate in the Jefferies London Healthcare..
31/10/202318:18PRNUSAlkermes Announces Effectiveness of Mural Oncology Form 10..
31/10/202318:08PRNUSAlkermes Announces Effectiveness of Mural Oncology Form 10..
25/10/202308:00PRNUSAlkermes plc Reports Third Quarter 2023 Financial Results
23/10/202309:00PRNUSAlkermes Presents First Clinical Data for Orexin 2 Receptor..
18/10/202317:00PRNUSAlkermes to Report Third Quarter Financial Results on..
10/10/202318:00PRNUSMural Oncology to Host Investor Webcast on October 17
10/10/202308:00PRNUSAlkermes to Present First Clinical Data for Orexin 2..
11/09/202308:00PRNUSAlkermes Presents Clinical and Real-World Data at 36th..
07/09/202308:00PRNUSAlkermes Announces Launch of 6th Annual Alkermes Pathways..
05/09/202317:00PRNUSAlkermes to Participate in Two Upcoming Investor Conferences
31/08/202308:00PRNUSAlkermes Announces Recipients of 2023 Alkermes Inspiration..
30/08/202308:00PRNUSAlkermes Announces Settlement With Teva Related to VIVITROL®..
26/07/202308:00PRNUSAlkermes plc Reports Second Quarter 2023 Financial Results
19/07/202317:31PRNUSAlkermes to Report Second Quarter Financial Results on July..
19/07/202317:03PRNUSAlkermes to Report Second Quarter Financial Results on July..
29/06/202311:54PRNUSAlkermes Shareholders Re-Elect All Seven Company Director..
29/06/202311:50PRNUSAlkermes Shareholders Re-Elect All Seven Company Director..
28/06/202308:30BWSarissa Capital Urges Alkermes Shareholders to Vote “FOR”..
26/06/202308:37BWSarissa Issues Presentation Highlighting Sarissa Nominees..
26/06/202308:00PRNUSRecently-Appointed Independent Directors of Alkermes Issue..
22/06/202307:25BWIndependent Proxy Advisory Firm ISS Agrees With Sarissa..
21/06/202309:00PRNUSIndependent Proxy Advisory Firm Glass Lewis Recommends..
20/06/202310:33BWIndependent Proxy Advisory Firm ISS Concludes That Sarissa..
20/06/202308:00PRNUSIndependent Proxy Advisory Firm ISS Recommends Alkermes..
15/06/202308:58BWSarissa Issues Presentation Highlighting the Need for..
13/06/202308:20BWSarissa Urges Shareholders to Vote for Sarissa Nominees to..
13/06/202308:00PRNUSAlkermes Issues Letter to Shareholders Highlighting Skills..
09/06/202308:00BWSarissa Capital Highlights Misleading Claims Made by..
08/06/202308:00PRNUSAlkermes Publishes Investor Presentation Detailing Company's..
06/06/202307:00PRNUSAlkermes Announces Final Award in Janssen Pharmaceutica..
05/06/202308:00BWSarissa Urges Alkermes Shareholders to Vote the Universal..
01/06/202317:01PRNUSAlkermes Appoints Caroline J. Loew, Ph.D., as Chief..
31/05/202317:00PRNUSAlkermes to Participate in Two Upcoming Investor Conferences
25/05/202317:15PRNUSAlkermes Files Definitive Proxy Statement and Issues Letter..

Seu Histórico Recente

NASDAQ
ALKS
Alkermes
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados